Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (121-130 of 364) with videos related to

Pageof 37
Sort By:
Clinical Pharmacokinetics|December 18, 2014
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's DiseaseDavid Ternant, Zahir Berkane, Laurence Picon, et al.
International Immunopharmacology|February 24, 2019
Beneficial effects of dual TORC1/2 inhibition on chronic experimental colitisShurong Hu, Mengmeng Cheng, Rong Fan, et al.
Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 17, 2019
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidenceTal Engel, Diana E Yung, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's DiseaseMarion Simon, Benjamin Pariente, Jérôme Lambert, et al.
Journal of Crohn'S & Colitis|January 24, 2016
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre ExperienceLaurent Peyrin-Biroulet, Julia Salleron, Jérôme Filippi, et al.
The Analyst|January 15, 2024
Sodium fluoride preserves blood metabolite integrity for biomarker discovery in large-scale, multi-site metabolomics investigationsWenzheng Xiong, Daniel C Anthony, Suzie Anthony, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2014
Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: a retrospective studyClotilde Baudry, Benjamin Pariente, Nelson Lourenço, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathiesGaëlle Varkas, Clio Ribbens, Edouard Louis, et al.
Journal of Crohn'S & Colitis|July 21, 2016
Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative StatisticsKonstantinos H Katsanos, Eugeni Domènech, Jean-François Rahier, et al.
Pageof 37

Showing results (121-130 of 364) with videos related to

Sort By:
Pageof 37
Clinical Pharmacokinetics|December 18, 2014
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's DiseaseDavid Ternant, Zahir Berkane, Laurence Picon, et al.
International Immunopharmacology|February 24, 2019
Beneficial effects of dual TORC1/2 inhibition on chronic experimental colitisShurong Hu, Mengmeng Cheng, Rong Fan, et al.
Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 17, 2019
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidenceTal Engel, Diana E Yung, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's DiseaseMarion Simon, Benjamin Pariente, Jérôme Lambert, et al.
Journal of Crohn'S & Colitis|January 24, 2016
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre ExperienceLaurent Peyrin-Biroulet, Julia Salleron, Jérôme Filippi, et al.
The Analyst|January 15, 2024
Sodium fluoride preserves blood metabolite integrity for biomarker discovery in large-scale, multi-site metabolomics investigationsWenzheng Xiong, Daniel C Anthony, Suzie Anthony, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2014
Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: a retrospective studyClotilde Baudry, Benjamin Pariente, Nelson Lourenço, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathiesGaëlle Varkas, Clio Ribbens, Edouard Louis, et al.
Journal of Crohn'S & Colitis|July 21, 2016
Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative StatisticsKonstantinos H Katsanos, Eugeni Domènech, Jean-François Rahier, et al.
Pageof 37